HomePBYI • NASDAQ
add
Puma Biotechnology Inc
Previous close
$4.50
Day range
$4.41 - $4.59
Year range
$2.32 - $6.06
Market cap
225.16M USD
Avg Volume
820.24K
P/E ratio
4.56
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 52.44M | 11.37% |
Operating expense | 33.50M | -13.22% |
Net income | 5.86M | 229.28% |
Net profit margin | 11.17 | 216.11% |
Earnings per share | 0.15 | 400.00% |
EBITDA | 9.40M | 1,189.30% |
Effective tax rate | 5.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 96.02M | -0.83% |
Total assets | 194.92M | -4.92% |
Total liabilities | 90.20M | -42.36% |
Total equity | 104.72M | — |
Shares outstanding | 50.37M | — |
Price to book | 2.14 | — |
Return on assets | 8.48% | — |
Return on capital | 10.61% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 5.86M | 229.28% |
Cash from operations | 14.08M | 1,271.18% |
Cash from investing | -11.25M | -1,700.00% |
Cash from financing | -11.20M | 1.15% |
Net change in cash | -8.37M | 12.85% |
Free cash flow | 11.30M | 375.12% |
About
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
Founded
2007
Headquarters
Website
Employees
172
